INDUSTRY PORTAL

KEY INFORMATION

Simple in design and practical in its application, the ProACT™ system is an alternative surgical treatment option to consider for all severities of stress urinary incontinence. Below are key device elements of ProACT. We encourage you to browse through the contents of this page to get more in-depth information on all things ProACT. If you’re looking to speak directly with a Uromedica Representative, click on the button below to send us a message. A Uromedica representative will respond in a timely manner.

KEY DEVICE ELEMENTS:

  • Adjustable to an individual patient’s needs

  • Minimally invasive procedure

  • 20-30-minute procedure

  • Passive Therapy

  • Indicated for all severities of SUI (mild, moderate, and severe)

  • Can be implanted if patient has a failed AUS or Sling

  • PROCTORING:

    One of our ProACT trainers and a field representative will come to the physician’s home facility to observe and talk their team through the procedure step by step. This allows the surgeon to not only ask questions but also gain hands on procedure experience under the guidance of a ProACT expert.

  • OBSERVATION:

    The interested surgeon will attend and observe cases at one of our training facilities. This allows the interested surgeon to learn how the procedure is performed by a highly experienced ProACT implanter.

Currently, we offer two training options for physicians to get trained on the ProACT procedure.

 

Our field representatives are eager to assist in working with you to get you to a training that fits your schedule.

To discuss training options or how to bring ProACT to your facility, click the “Talk to our team” button above to get in touch with a Uromedica Representative. 

TRAINING OPTIONS

PUBLICATIONS + UROMEDICA IN THE NEWS:

 

There are over 40 publications on the ProACT system. The following are some of the most recent and up-to-date publications available.

Munier P, Nicolas M, Tricard T, et al. What if artificial urinary sphincter is not possible?  Feasibility and effectiveness of ProACT for patients with persistent stress urinary incontinence after radical prostatectomy treated by sling.  Neurourol. Urodyn. 06 April 2020:1-6. doi:10.1002/nau.24355..

Noordhoff TC, Finazzi-Agrò E, Scheepe JR, Blok BFM. Outcome and complications of adjustable continence therapy (ProACTTM) in the treatment of urinary incontinence after transurethral resection of the prostate: A multicenter study. Neurourol Urodyn. 2019 Apr;38(4):1111-1119. doi: 10.1002/nau.23966.

Larson T, Jhaveri H, Yeung LL. Adjustable continence therapy (ProACT) for the treatment of male stress urinary incontinence: A systematic review and metaanalysis. Neurourology and Urodynamics. 2019; 38(8):2051-2059. doi: 10.1002/nau.2413.

Finazzi Agrò E, Gregori A, Bianchi D, et al. Efficacy and safety of adjustable balloons (Proact™) to treat male stress urinary incontinence after prostate surgery: Medium and long‐term follow‐up data of a national multicentric retrospective study. Neurourol Urodyn. 2019 Sep;38(7):1979-1984. doi: 10.1002/nau.24103.

Nash S, Aboseif S, Gilling P, Gretzer M, Samowitz H, Rose M, Slutsky J, Siegel S, Tu LM. Four-year follow-up on 68 patients with a new post-operatively adjustable long-term implant for post-prostatectomy stress incontinence: ProACT™. Neurourol Urodyn. 2019; 38(1): 248-253. doi: 10.1002/nau.23838.

PRO-US-20-009

1840 BERKSHIRE LN N

PLYMOUTH, MN 55441

763-694-9880

  • Facebook
  • Twitter
  • YouTube